Monthly Archives: March 2013

The Varieties of Pharma Disclosure

The variations around corporate disclosure displayed by pharma companies generally fall in a range from amusing to frustrating to baffling. Over the past month, three contrasting approaches crossed our radar, and warrant mention: 1) Acadia Pharmaceuticals waited until the AAN … Continue reading

Posted in Big Pharma, Biotech | Tagged | 1 Comment